RT @FrontNeurol: New Research: Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, ran…
485 followers
19,107 followers
Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive…#FrontiersIn #Neurology https://t.co/xYIje
213 followers
RT @FrontNeurol: New Research: Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, ran…
10,607 followers
New Research: Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive… https://t.co/xBqPANpi8q #Fro